Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Potter

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonistE Chu, T C Chu, D E Potter
American Journal of Diseases of Children (1960)|November 1, 1978
Avascular necrosis of bone after renal transplantationD E Potter, H K Genant, O Salvatierra
Experimental Eye Research|January 6, 2000
Potential sites of action of TNPA: a dopamine-2 receptor agonistE Chu, T C Chu, D E Potter
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Ocular actions of moxonidine: a possible role for imidazoline receptorsM Ogidigben, T C Chu, D E Potter
Experimental Eye Research|June 1, 1994
Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxinM Ogidigben, T C Chu, D E Potter
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphineM Ogidigben, T C Chu, D E Potter
Pharmacology|January 1, 1982
Effects of ethanol, acetaldehyde and acetate on insulin release from perifused pancreatic isletsD E Potter, J W Morris, J M Rowland
Journal of Ocular Pharmacology|January 1, 1985
Mechanism of the ocular hypotensive action of ketanserinF W Chang, J A Burke, D E Potter
Current Eye Research|February 1, 1985
Forskolin suppresses sympathetic neuron function and causes ocular hypotensionD E Potter, J A Burke, J R Temple
Current Eye Research|January 1, 1982
Ocular hypertensive response to beta-adrenoceptor agonistsD E Potter, H T Nicholson, J M Rowland
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonistE Chu, T C Chu, D E Potter
American Journal of Diseases of Children (1960)|November 1, 1978
Avascular necrosis of bone after renal transplantationD E Potter, H K Genant, O Salvatierra
Experimental Eye Research|January 6, 2000
Potential sites of action of TNPA: a dopamine-2 receptor agonistE Chu, T C Chu, D E Potter
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Ocular actions of moxonidine: a possible role for imidazoline receptorsM Ogidigben, T C Chu, D E Potter
Experimental Eye Research|June 1, 1994
Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxinM Ogidigben, T C Chu, D E Potter
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphineM Ogidigben, T C Chu, D E Potter
Pharmacology|January 1, 1982
Effects of ethanol, acetaldehyde and acetate on insulin release from perifused pancreatic isletsD E Potter, J W Morris, J M Rowland
Journal of Ocular Pharmacology|January 1, 1985
Mechanism of the ocular hypotensive action of ketanserinF W Chang, J A Burke, D E Potter
Current Eye Research|February 1, 1985
Forskolin suppresses sympathetic neuron function and causes ocular hypotensionD E Potter, J A Burke, J R Temple
Current Eye Research|January 1, 1982
Ocular hypertensive response to beta-adrenoceptor agonistsD E Potter, H T Nicholson, J M Rowland
Pageof 10